Login / Signup

Comparative early effectiveness across 14 PsA drugs and 5 classes of PsA treatment: 3-month results from the PRO-SPIRIT study.

Lars Erik KristensenKhai Jing NgMarcus NgantchaJacques MorelEnnio LubranoWilliam TillettRieke E AltenVinod ChandranÀngels Martinez FerrerBaojin ZhuDominika KennedyThorsten HolzkämperNicola J GullickAndris KronbergsWalid FakhouriInmaculada de la TorreDennis G McGonagle
Published in: RMD open (2024)
This study confirms the rapid 3-month effectiveness of IXE on joint disease activity-as fast as TNFi and JAKi (cDAPSA), and exceeding IL-12/23i and IL-23i-along with clear benefits to skin.
Keyphrases
  • disease activity
  • prostate cancer
  • rheumatoid arthritis
  • randomized controlled trial
  • systemic lupus erythematosus
  • systematic review
  • ankylosing spondylitis
  • radical prostatectomy
  • anti inflammatory